title: Differences and similarities between two frequently used assays for amyloid beta 42 in cerebrospinal fluid.
authors.affiliation: Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands. niki.schoonenboom@vumc.nl
authors.forename: Niki S M
authors.initials: NS
authors.lastname: Schoonenboom
authors.forename: Cees
authors.initials: C
authors.lastname: Mulder
authors.forename: Hugo
authors.initials: H
authors.lastname: Vanderstichele
authors.forename: Yolande A L
authors.initials: YA
authors.lastname: Pijnenburg
authors.forename: Gerard J
authors.initials: GJ
authors.lastname: Van Kamp
authors.forename: Philip
authors.initials: P
authors.lastname: Scheltens
authors.forename: Pankaj D
authors.initials: PD
authors.lastname: Mehta
authors.forename: Marinus A
authors.initials: MA
authors.lastname: Blankenstein
mesh_terms: D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis; D016229:Amyloid beta-Peptides / Q000134:cerebrospinal fluid*; D003704:Dementia / Q000175:diagnosis; D005260:Female; D006801:Humans; D007118:Immunoassay / Q000379:methods; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000134:cerebrospinal fluid*; D012372:ROC Curve; D012680:Sensitivity and Specificity
chemical_list: D016229:Amyloid beta-Peptides; D010446:Peptide Fragments; C075222:amyloid beta-protein (1-42)